Nonetheless, the selective activation of the cGAS-STING pathway and the stimulation of cancer-cell-intrinsic immunity by POLE mutations provide a theoretical-foundations for accurate molecular typing and personalized therapy of malignant tumors. The gene discussed is STING1; the disease is cancer.